|This article does not cite any references or sources. (December 2009)|
The development of an imaging agent involves synthesizing the agent to target a particular tumor or process, after which the imaging instruments can be adjusted to neutralize the target. Such agents are first examined via preclinical animal studies before engaging in early-phase human clinical studies.
|This oncology article is a stub. You can help Wikipedia by expanding it.|